Kempner Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Kempner Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-108,144	Closed	-$6.12M	–	50
2024 Q4	$6.12M	Hold	108,144	–	–	3.36%	8
2024 Q3	$5.59M	Hold	108,144	–	–	2.86%	15
2024 Q2	$4.49M	Buy	108,144 +20,112	+23%	+$900K	2.38%	23
2024 Q1	$4.77M	Buy	88,032 +18,671	+27%	+$951K	2.59%	20
2023 Q4	$3.56M	Buy	69,361 +20,366	+42%	+$1.07M	1.99%	27
2023 Q3	$2.84M	Buy	+48,995	New	+$3M	1.71%	28
2022 Q3	–	Sell	-27,238	Closed	-$2.1M	–	62
2022 Q2	$2.1M	Sell	27,238 -9,107	-25%	-$694K	1.28%	34
2022 Q1	$2.65M	Sell	36,345 -12,404	-25%	-$833K	1.45%	33
2021 Q4	$3.04M	Sell	48,749 -151	-0.3%	-$8.86K	1.79%	26
2021 Q3	$2.89M	Hold	48,900	–	–	1.65%	26
2021 Q2	$3.27M	Hold	48,900	–	–	1.85%	22
2021 Q1	$3.09M	Hold	48,900	–	–	1.77%	24
2020 Q4	$3.03M	Buy	48,900 +14,095	+40%	+$867K	2%	24
2020 Q3	$2.1M	Buy	+34,805	New	+$2.09M	1.68%	30

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Kempner Capital Management's BMY Position: Q1 2025 in Review

Kempner Capital Management sold out of Bristol-Myers Squibb (BMY) in Q1 2025, closing a stake of 108,144 shares — an estimated $6.12M sold.

Kempner Capital Management first reported a position in BMY in Q3 2020 and held it in 14 quarters. The position peaked at $6.12M in Q4 2024. 2,478 funds tracked by Wall St. Rank hold BMY as of Q1 2025.

Kempner Capital Management reported no remaining Bristol-Myers Squibb position as of Q1 2025 after selling out during the quarter.
Kempner Capital Management sold 108,144 Bristol-Myers Squibb shares in Q1 2025, an estimated $6.12M.
Kempner Capital Management first reported a position in Bristol-Myers Squibb in Q3 2020 and held it in 14 quarters.
Kempner Capital Management's Bristol-Myers Squibb position peaked at $6.12M in Q4 2024.
2,478 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2025.

Based on Kempner Capital Management's 13F filing for Q1 2025, filed 21 Apr 2025.